| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/20/2001 | WO2001068119A1 Atherosclerosis vaccine |
| 09/20/2001 | WO2001068116A2 Immunostimulatory polynucleotide sequences for use in preventing and treating respiratory viral infections |
| 09/20/2001 | WO2001068103A2 Treatment of herpes infection using immunomodulatory polynucleotide sequences |
| 09/20/2001 | WO2001068077A2 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections |
| 09/20/2001 | WO2001068053A2 Methods and compositions for treating and preventing posterior segment ophthalmic disorders |
| 09/20/2001 | WO2001042439A8 Molecular display on multimeric protein scaffolds derived from the e2 component of the alpha-ketoacid dehydrogenase |
| 09/20/2001 | WO2001029070A8 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 09/20/2001 | WO2001025272A3 Compositions and methods for therapy and diagnosis of prostate cancer |
| 09/20/2001 | WO2001018051A3 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 09/20/2001 | WO2001014424A3 Human ctla-4 antibodies and their uses |
| 09/20/2001 | WO2001013944A3 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 09/20/2001 | WO2001013943A3 Stress protein-peptide complexes as vaccines against intra cellular pathogens |
| 09/20/2001 | WO2001013942A3 Trehalose producing prokaryotic cells as vaccines |
| 09/20/2001 | WO2001012661A3 RECEPTOR-MEDIATED UPTAKE OF AN EXTRACELLULAR BCL-xL FUSION PROTEIN INHIBITS APOPTOSIS |
| 09/20/2001 | WO2001012223A3 Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein |
| 09/20/2001 | WO2001008702A9 Immunotherapy in hiv infected persons using vaccines after multi-drug treatment |
| 09/20/2001 | WO2000037490A3 Outer surface proteins, their genes, and their use |
| 09/20/2001 | US20010023240 Compounds and compositions for delivering active agents |
| 09/20/2001 | US20010022969 Sepsis therapy |
| 09/20/2001 | DE10011358A1 Producing a modified L-form bacterial strain by culturing the strain in complex medium and subjecting it to temperature stress, provides bacteria useful to produce recombinant proteins |
| 09/20/2001 | DE10010165A1 Composition for tumor treatment, comprises tumor antigen and recall antigen that stimulates attack by T cells, overcoming tolerance to the tumor |
| 09/20/2001 | DE10009030A1 Hybrid cell, useful as therapeutic vaccine against cancer and viral, bacterial and protozoal infections, comprises allogeneic dendritic cells fused to autologous non-dendritic cells |
| 09/20/2001 | CA2403393A1 Methods and compositions for immunoregulation |
| 09/20/2001 | CA2403084A1 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia" |
| 09/20/2001 | CA2402940A1 G-protein coupled receptors |
| 09/20/2001 | CA2402935A1 Adjuvant for vaccines |
| 09/20/2001 | CA2402807A1 Pneumococcus polysaccharide conjugates for use as vaccine against tetanus and diphtheria |
| 09/20/2001 | CA2402721A1 Derivatives of breast cancer antigen her-2 for therapeutical use |
| 09/20/2001 | CA2402718A1 Fish vaccine against piscirickettsia salmonis |
| 09/20/2001 | CA2402327A1 Peptides targeting specifically tumor-derived endothelial cells |
| 09/20/2001 | CA2402312A1 Treatment of herpes infection using immunomodulatory polynucleotide sequences |
| 09/20/2001 | CA2402294A1 Immunomodulatory formulations and methods for use thereof |
| 09/20/2001 | CA2402259A1 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections |
| 09/20/2001 | CA2402248A1 Polypeptides and nucleic acids encoding same |
| 09/20/2001 | CA2402237A1 Improved methods to isolate, identify, quantify, and propagate chicken infectious anemia virus and high titer vaccine |
| 09/20/2001 | CA2402086A1 Self antigen vaccines for treating b cell lymphomas and other cancers |
| 09/20/2001 | CA2401252A1 Human and humanized fap-alpha-specific antibodies |
| 09/20/2001 | CA2400106A1 Antibodies to human cd154 |
| 09/20/2001 | CA2373237A1 Methods and compositions for treating and preventing posterior segment ophthalmic disorders |
| 09/19/2001 | EP1133994A1 A method for reversing the immunosuppressive effects of the Melanoma Inhibitory Activity "MIA" |
| 09/19/2001 | EP1133988A1 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene |
| 09/19/2001 | EP1133575A2 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
| 09/19/2001 | EP1133572A2 Chlamydia pneumoniae genome sequence |
| 09/19/2001 | EP1133563A2 Methods and molecules relating to cd39-like polypeptides |
| 09/19/2001 | EP1133561A2 Protein fragments for use in protein targeting |
| 09/19/2001 | EP1133520A2 Compositions and methods using lactadherin or variants thereof |
| 09/19/2001 | EP1133516A1 Chromosome 17p-linked prostate cancer susceptibility gene |
| 09/19/2001 | EP1133315A1 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases |
| 09/19/2001 | EP1133311A2 INFLUENCING OF ANGIGENESIS USING CD66a |
| 09/19/2001 | EP1133310A2 Artery- and vein-specific proteins and uses therefor |
| 09/19/2001 | EP0862634B1 Pharmaceutical composition for treating papillomavirus tumours and infection |
| 09/19/2001 | EP0831901B1 Vaccine comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein |
| 09/19/2001 | EP0612244B1 Endothelin receptor antagonists |
| 09/19/2001 | EP0603406B1 Fowl mycoplasma antigen, gene thereof, recombinant vector containing said gene, and vaccine prepared by utilizing the same |
| 09/19/2001 | EP0591369B1 Capsid forming and cystein modified chimaeric ms2-coat protein |
| 09/19/2001 | CN1313903A Compound and method for the prevention and/or the treatment of allergy |
| 09/19/2001 | CN1313897A New gene of humanlysoenzyme, the encoding polypeptide and methods for preparing them |
| 09/19/2001 | CN1313895A Useful properties of a bee venom protein and gene encoding same |
| 09/19/2001 | CN1313864A Particles of HCV envelope proteins use of vaccination |
| 09/19/2001 | CN1313775A Methods and materials for the treatment of prostatic cercinoma |
| 09/19/2001 | CN1313774A Vaccine comprising cytokine-induced heat shock proteins |
| 09/19/2001 | CN1313773A Antigenic peptides derived from telomerase |
| 09/19/2001 | CN1313772A Peptide antagonists of zonulin and methods for use of same |
| 09/18/2001 | USRE37381 Attenuated cdna sequence; genetic engineering; mutants |
| 09/18/2001 | US6291664 Method of eliminating inhibitory/instability regions of mRNA |
| 09/18/2001 | US6291663 TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma |
| 09/18/2001 | US6291661 flt3-L mutants and method of use |
| 09/18/2001 | US6291654 Obtaining protein sample from bacteria, applying to solid support of methylamine treated complement protein c3, washing solid support, and removing c3 binding protein from solid support using alcohol solution |
| 09/18/2001 | US6291649 Anti-bodies binding adhesin-derived antigens |
| 09/18/2001 | US6291645 A polypeptide that modulates lymphocytes; diagnosis and therapy of cevical cancer, promotes wound healing and hair growth |
| 09/18/2001 | US6291643 Apaf-1 an activator of caspase-3 |
| 09/18/2001 | US6291641 Hepatitis E virus antigens and uses therefor |
| 09/18/2001 | US6291517 Method for preventing or reducing stress-induced gastric injury using grape seed proanthocyanidin extract |
| 09/18/2001 | US6291500 Administering an antifungal agent |
| 09/18/2001 | US6291496 Treating cancers associated with overexpression of class I family of receptor tyrosine kinases |
| 09/18/2001 | US6291437 The protein/nucleic acid compositions are administered in an amount capable of inducing cell mediated immunity and/or antibody response in the subject. |
| 09/18/2001 | US6291431 Methods and compositions for the treatment and prevention of Staphylococcal infections |
| 09/18/2001 | US6291430 Mage-3 peptides presented by HLA class II molecules |
| 09/18/2001 | US6291237 Cancer diagnosis and therapy based on mutations in TGF-β receptors |
| 09/18/2001 | US6291236 Human cytomegalovirus DNA sequences |
| 09/18/2001 | US6291228 Vaccine |
| 09/18/2001 | US6291227 Nucleotide sequences coding viral polypeptides; for use in the development of vaccines which prevent retroviral infections |
| 09/18/2001 | US6291226 Adenovirus mutants with deleted protease gene |
| 09/18/2001 | US6291225 Microorganismal material for use in the treatment, diagnosis and prevention of microorganismal infection |
| 09/18/2001 | US6291217 Glutathionylspermidine synthetase and processes for recovery and use thereof |
| 09/18/2001 | US6291216 Aliphatic hydroxy base bonded to oxirane-containing polymer through thiophilic or metal chelation group ligand; immobilized enzymes; chromatography |
| 09/18/2001 | US6291208 Exprsssion vector; for use as diagnostic tools and generating vaccines |
| 09/18/2001 | US6291197 Binding moieties for human parvovirus B19 |
| 09/18/2001 | US6291193 MTbx protein and nucleic acid molecules and uses therefor |
| 09/18/2001 | US6291157 Detecting retroviral antigens in samples by immunizing the host with an immunogenic non-infectious, non-replicating virus particles producing antibodies, mixing sample with retroviral antigen antibodies, detecting immune complexes |
| 09/18/2001 | US6290973 Vaccines for bacterial and viral diseases |
| 09/18/2001 | US6290971 Adjuvant compositions comprising a mineral salt and another immunostimulating compound |
| 09/18/2001 | US6290970 Transferrin receptor protein of Moraxella |
| 09/18/2001 | US6290969 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 09/18/2001 | US6290968 Genes are provided solely from the bovine rotavirus wc3 strain, or from both the human and bovine strains. |
| 09/18/2001 | US6290967 Stabilizers for lyophilized vaccines |
| 09/18/2001 | US6290965 DNA encoding human papillomavirus type 6A |
| 09/18/2001 | US6290962 Urease-based vaccine and treatment for helicobacter infection |
| 09/18/2001 | US6290961 Method for treating dystonia with botulinum toxin type B |
| 09/18/2001 | US6290960 Vaccine and antitoxin for the treatment of C. difficile disease |